Epidemiological Determinants of Anemia

1. Global Burden

2. Nutritional Determinants

Iron Deficiency (the leading cause)

• Accounts for ~50% of all anemia cases worldwide (roughly 500 million cases).
• Iron-amenable share of anemia is highest in Central Asia (65%), South Asia (55%), and Andean Latin America (62%).
• Caused by:
  • Inadequate dietary intake (low heme-iron diets, poor bioavailability from plant-based foods)
  • Increased physiologic demand (growth in children, pregnancy, lactation)
  • Chronic blood loss (menstruation, hookworm, peptic ulcer, colorectal pathology)
  • Malabsorption (celiac disease, gastric bypass, atrophic gastritis)
• In the United States: 11% of preschool children, 14.7% of premenopausal women, and 18% of pregnant women have iron deficiency (Tietz Textbook of Laboratory Medicine, 7th Ed.).

Other Nutritional Deficiencies

• Vitamin B12 deficiency: Megaloblastic anemia; linked to strict vegetarian/vegan diets, autoimmune gastritis (pernicious anemia), and malabsorption syndromes (terminal ileal disease).
• Folate deficiency: Common in pregnancy, alcoholism, and populations with low green leafy vegetable consumption.
• Vitamin A deficiency: Impairs erythropoiesis; synergistic with iron deficiency in developing countries.

3. Demographic Determinants

Age

• Young children (6-24 months): Highest risk due to rapid growth demands and transition from milk-based diets low in iron.
• Adolescent females: High risk secondary to growth spurts plus onset of menstruation. NHANES 2021-2023 data showed 17.4% prevalence in U.S. girls aged 12-19.
• Pregnant women: Iron requirements roughly triple; global incidence of anemia in pregnancy remains ~38%.
• Elderly (>60 years): Prevalence rises significantly (12.5% in U.S. adults ≥60 years in NHANES data). Causes shift toward anemia of chronic disease/inflammation, renal insufficiency, myelodysplasia, and multifactorial anemia.

Sex

• Females consistently show higher prevalence than males across all racial/ethnic groups and income levels.
• The female-to-male disparity is most pronounced during reproductive years due to menstrual losses and pregnancy demands.
• In men ≥60 years, prevalence approaches women's rates as hormonal and nutritional gaps narrow and chronic disease burden increases.

4. Geographic and Socioeconomic Determinants

• Low- and middle-income countries (LMICs): Carry the overwhelming majority of the global burden due to poor dietary diversity, food insecurity, tropical infections, and limited healthcare access.
• Income: A clear dose-response relationship exists. In U.S. NHANES data, anemia prevalence was 14.1% at <130% poverty level versus 5.7% at ≥350% poverty level - more than double the risk in the lowest income bracket.
• Education: Lower health literacy is associated with poor dietary practices and delayed care-seeking.
• Rural vs. urban: Rural populations in LMICs face compounded risks - poor sanitation (hookworm), limited fortified foods, less access to prenatal care.
• Socioeconomic Development Index (SDI): Negative correlation between SDI and anemia burden is well-established in GBD analyses.

5. Infectious Disease Determinants

• Malaria: A leading cause of severe anemia in children in sub-Saharan Africa, through hemolysis, dyserythropoiesis, and splenic sequestration.
• Hookworm (Necator americanus, Ancylostoma duodenale): Chronic intestinal blood loss leads to iron-deficiency anemia; significant in tropical regions. Clinical anemia typically appears at ≥2000 eggs/gram of feces (Goldman-Cecil Medicine).
• HIV/AIDS: Multifactorial anemia via bone marrow suppression, opportunistic infections, drug effects (e.g., zidovudine), and nutritional deficiency.
• Tuberculosis and chronic infections: Trigger inflammatory cytokines (IL-6, hepcidin) that impair iron recycling and erythropoiesis - the mechanism of anemia of inflammation.
• Helicobacter pylori: Reduces gastric acid secretion and competes for dietary iron, contributing to iron deficiency, particularly in children.

6. Genetic Determinants

• Hemoglobinopathies: Sickle cell disease and thalassemias (alpha and beta) represent the most prevalent inherited causes.
  • Highest frequency in malaria-endemic regions (Africa, Mediterranean, Middle East, Southeast Asia) due to heterozygous protection against Plasmodium falciparum.
  • Globally, >300,000 babies are born each year with a severe hemoglobinopathy.
• G6PD deficiency: X-linked; triggers episodic hemolytic anemia upon oxidant stress (infections, drugs, fava beans); prevalent in same geographic zones as malaria.
• Hereditary spherocytosis and elliptocytosis: Less geographically concentrated but notable causes of chronic hemolytic anemia.

7. Racial and Ethnic Determinants

• Black non-Hispanic: 22.0% prevalence
• Asian non-Hispanic: 11.8%
• Hispanic: 10.9%
• White non-Hispanic: 6.1%

8. Chronic Disease and Iatrogenic Determinants

• Chronic kidney disease (CKD): Reduced erythropoietin (EPO) production is the primary driver; compounded by functional/absolute iron deficiency. Hemoglobin <11 g/dL is present in 42.2% of subjects with eGFR significantly reduced (Brenner & Rector's The Kidney).
• Inflammatory and autoimmune diseases (rheumatoid arthritis, IBD, SLE): Elevated hepcidin blocks ferroportin-mediated iron release, causing anemia of inflammation.
• Malignancies and chemotherapy: Bone marrow infiltration, cytotoxic drug effects, and chronic blood loss.
• Medications: Antiplatelet agents and anticoagulants (GI bleeding), NSAIDs (gastric erosions), and myelosuppressive drugs.

9. Obstetric and Reproductive Determinants

• Pregnancy: Iron requirements increase from ~1 mg/day to ~6 mg/day in the third trimester; insufficient supplementation or closely spaced pregnancies amplify risk.
• Multiparity and short inter-pregnancy intervals: Deplete maternal iron stores.
• Maternal anemia is transmitted: A 2024 systematic review (Zhao et al., PMID 39425056) confirmed a significant association between maternal anemia and neonatal anemia.

Summary Table

• Tietz Textbook of Laboratory Medicine, 7th Ed. (Iron Deficiency section)
• Goldman-Cecil Medicine (hookworm and chronic infection sections)
• Brenner & Rector's The Kidney (CKD anemia section)
• CDC NHANES Data Brief 519, December 2024 (U.S. prevalence by demographics)
• GBD 2019/2021 Anemia analyses (global burden data)
• Zhao et al. (2024) - Maternal and neonatal anemia association [PMID 39425056]

National Strategies and Activities for Prevention and Control of Anemia in Nepal

Current Burden (NDHS 2022 Baseline)

National Policy Framework

1. National Nutrition Policy and Strategy (2004, updated)

• Supplementation
• Food fortification
• Infection control
• Health service strengthening

2. Multi-Sector Nutrition Plan (MSNP)

Core Program Interventions

A. Iron and Folic Acid (IFA) Supplementation Program

• Female Community Health Volunteers (FCHVs): The backbone of community-level distribution. FCHVs distribute IFA door-to-door and during mothers' group meetings.
• Health facilities: IFA given at every ANC visit (ANC-IFA integration).
• Schools: Teachers distribute weekly IFA tablets to adolescent girls.

• 94% of women who gave birth in the preceding five years received or purchased iron supplements during their last pregnancy.
• 87% of women took iron for at least 90 days during their last pregnancy.
• 65% took iron for 180 days or more.
• Anemia in pregnant women decreased from 42% (2011) to 32.7% (2022).

• While coverage is high (~80% of women receive IFA), compliance (completing the full 180-day course) remains at only ~50-52%.
• Common reasons for dropout: nausea, constipation, black stools, forgetfulness, and lack of counseling on side effect management.
• Periodic stock-outs at health posts and FCHV level.

B. Weekly Iron and Folic Acid Supplementation (WIFS) for Adolescent Girls

• Dose: 1 tablet weekly containing 60 mg elemental iron + 400 mcg folic acid
• Distribution Schedule: Two phases per year - Phase 1 (Shrawan-Ashoj, 13 tablets) and Phase 2 (Magh-Chaitra, 13 tablets), with a 3-month gap between phases
• Delivery: Primarily school-based (teachers or health focal persons)
• Coupled with: Bi-annual deworming (albendazole 400 mg)
• Rationale: Reducing anemia before girls enter pregnancy, improving cognitive development and school performance
• Now integrated into the Multi-Sector Nutrition Plan (MSNP)

C. Deworming Programs

• School Health and Nutrition Program: All government school children receive deworming tablets (albendazole) bi-annually.
• Pregnant women: Deworming in the 2nd trimester as part of ANC protocol.
• Children 1-5 years: Deworming as part of integrated child health programs.
• Limitation: Private school students and out-of-school adolescents historically excluded from school-based deworming.

D. Food Fortification

• Iron
• Folic acid
• Vitamin A

E. Vitamin A Supplementation

• Post-partum mothers: Vitamin A supplementation at 200,000 IU as a single dose shortly after delivery (within 6 weeks), since Vitamin A deficiency impairs erythropoiesis and compounds iron-deficiency anemia.
• Children 6-59 months: Twice-yearly Vitamin A supplementation during Child Health Days (vitamin A + deworming + ORS distribution), delivered through FCHVs.

F. Maternal and Child Health Programs with Anemia Components

1. National Safe Motherhood Program: Ensures ANC attendance (minimum 4 visits, now targeting 8+ visits per WHO 2016 guidelines), which is the primary platform for IFA distribution and hemoglobin testing.
2. Birth Preparedness Program: Promotes early ANC registration (within first trimester) to maximize duration of IFA supplementation.
3. Family Planning Program: Promotes birth spacing (reduces iron depletion from closely spaced pregnancies). Nepal's Sustainable Development Goals target delayed first birth and 3-year birth intervals.
4. FCHV Program: ~50,000 FCHVs across Nepal provide IFA, counseling on nutrition, and referral for anemia management at the household level.
5. Primary Health Care Outreach Program (PHCOP): Reaches remote populations with a package including IFA, Vitamin A, deworming, and immunization.

G. Malaria Control

• Indoor residual spraying (IRS)
• Insecticide-treated net (ITN) distribution
• Early diagnosis and treatment with artemisinin-based combination therapy (ACT)

H. Nutrition-Sensitive Agriculture and WASH Interventions

• Agriculture/Livestock: Promotion of diversified homestead food production (vegetable gardens, poultry), bio-fortified crops (orange sweet potato, iron-rich beans), and nutrition-sensitive agriculture to improve dietary iron availability.
• School Garden Program: An RCT in Nepal (Baliki et al., 2023 - PMID 37728126) showed integrated school and home garden interventions significantly reduced anemia in school-aged children.
• WASH: Improved sanitation and access to clean water reduces the burden of diarrheal diseases and parasitic infections that worsen anemia. National campaigns promote handwashing and open defecation-free communities (ODF).
• Social Protection: Cash transfer programs (Child Protection Grant, social security allowances) improve household purchasing power for diverse, nutrient-rich diets.

I. Behavior Change Communication (BCC) and Health Education

• Nutrition education through FCHVs, ANC counseling, and mothers' group meetings.
• Community awareness on iron-rich foods (leafy greens, meat, legumes), vitamin C co-consumption to enhance iron absorption, and avoidance of tea/coffee with meals.
• An RCT in Western Nepal (Sakai et al., 2024 - PMID 39348362) demonstrated that art-based health education significantly improved anemia and health literacy outcomes in pregnant women, suggesting potential for innovative BCC strategies.

Key Challenges Undermining Program Effectiveness

1. Low compliance despite high coverage of IFA distribution (~50-52% complete the 180-day course)
2. High anemia in children under 2 years (66% in 6-23 months group) - existing programs inadequately address this window
3. Geographic disparities: Terai provinces (Madhesh, Lumbini) and Karnali have disproportionately high burdens
4. Multi-factorial etiology: Iron deficiency accounts for only a portion of anemia; infections, vitamin A deficiency, chronic disease, and genetic factors require parallel interventions
5. Supply chain failures: Periodic IFA stock-outs at peripheral levels
6. Coverage gaps in adolescents: Out-of-school girls and private school students remain underserved
7. Slow rate of reduction: At current trajectory, Nepal is unlikely to meet SDG 2030 targets (10% for both groups) without accelerated action

MSNP-III Targets for Anemia (2023-2030)

• Nepal NDHS 2022 (DHS Program)
• MSNP-III Synopsis (Government of Nepal)
• Bibalex.org / Nepal IFA Program Report (MoHP/FCHV program documentation)
• Madan Bhandari Academy - IFA Program in Nepal (2025 presentation)
• Paudyal et al. (2022) - Review of maternal IFA supplementation programme in Nepal [cited in PMC10918752]
• Baliki et al. (2023) School/home garden RCT [PMID 37728126]
• Sakai et al. (2024) Art-based health education RCT [PMID 39348362]
• WHO Expert Consultation on Strategies to Prevent Anaemia (IRIS/WHO)